Application 211685

Type
ANDA
Sponsor
APOTEX

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PREGABALINPREGABALINCAPSULE;ORAL25MGNoNo
002PREGABALINPREGABALINCAPSULE;ORAL50MGNoNo
003PREGABALINPREGABALINCAPSULE;ORAL75MGNoNo
004PREGABALINPREGABALINCAPSULE;ORAL100MGNoNo
005PREGABALINPREGABALINCAPSULE;ORAL150MGNoNo
006PREGABALINPREGABALINCAPSULE;ORAL200MGNoNo
007PREGABALINPREGABALINCAPSULE;ORAL225MGNoNo
008PREGABALINPREGABALINCAPSULE;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60505-3793PregabalinPregabalinApotexCorpANDACurrent
60505-3794PregabalinPregabalinApotexCorpANDACurrent
60505-3795PregabalinPregabalinApotexCorpANDACurrent
60505-3796PregabalinPregabalinApotexCorpANDACurrent
60505-3797PregabalinPregabalinApotexCorpANDACurrent
60505-3798PregabalinPregabalinApotexCorpANDACurrent
60505-3799PregabalinPregabalinApotexCorpANDACurrent
60505-3800PregabalinPregabalinApotexCorpANDACurrent